In EDS ansehen

Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future.

Gespeichert in:
Bibliographische Detailangaben
Titel: Extracellular Vesicles in Musculoskeletal Regeneration: Modulating the Therapy of the Future.
Autoren: Abreu, Hugo, Canciani, Elena, Raineri, Davide, Cappellano, Giuseppe, Rimondini, Lia, Chiocchetti, Annalisa
Quelle: Cells (2073-4409); Jan2022, Vol. 11 Issue 1, p43, 1p
Schlagwörter: EXTRACELLULAR vesicles, REGENERATION (Biology), STROMAL cells, REGENERATIVE medicine, MUSCULOSKELETAL system diseases, VESICLES (Cytology)
Abstract: Tissue regeneration is a hot topic in health sciences, particularly because effective therapies promoting the healing of several cell types are lacking, specifically those of the musculoskeletal system. Mesenchymal Stem/Stromal Cells (MSCs) have been identified as crucial players in bone homeostasis, and are considered a promising therapy for diseases such as osteoarthritis (OA) and Rheumatoid Arthritis (RA). However, some known drawbacks limit their use, particularly ethical issues and immunological rejections. Thus, MSCs byproducts, namely Extracellular Vesicles (EVs), are emerging as potential solutions to overcome some of the issues of the original cells. EVs can be modulated by either cellular preconditioning or vesicle engineering, and thus represent a plastic tool to be implemented in regenerative medicine. Further, the use of biomaterials is important to improve EV delivery and indirectly to modulate their content and secretion. This review aims to connect the dots among MSCs, EVs, and biomaterials, in the context of musculoskeletal diseases. [ABSTRACT FROM AUTHOR]
Copyright of Cells (2073-4409) is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Datenbank: Complementary Index
Beschreibung
Abstract:Tissue regeneration is a hot topic in health sciences, particularly because effective therapies promoting the healing of several cell types are lacking, specifically those of the musculoskeletal system. Mesenchymal Stem/Stromal Cells (MSCs) have been identified as crucial players in bone homeostasis, and are considered a promising therapy for diseases such as osteoarthritis (OA) and Rheumatoid Arthritis (RA). However, some known drawbacks limit their use, particularly ethical issues and immunological rejections. Thus, MSCs byproducts, namely Extracellular Vesicles (EVs), are emerging as potential solutions to overcome some of the issues of the original cells. EVs can be modulated by either cellular preconditioning or vesicle engineering, and thus represent a plastic tool to be implemented in regenerative medicine. Further, the use of biomaterials is important to improve EV delivery and indirectly to modulate their content and secretion. This review aims to connect the dots among MSCs, EVs, and biomaterials, in the context of musculoskeletal diseases. [ABSTRACT FROM AUTHOR]
ISSN:20734409
DOI:10.3390/cells11010043